Gene and Cell Therapies Targeting CNS Disorders Market
According to Intent Market Research, the Gene And Cell Therapies Targeting CNS Disorders Market is expected to grow from USD 7.5 billion in 2023 at a CAGR of 7.0% to touch USD 12.0 billion by 2030. The Gene And Cell Therapies Targeting CNS Disorders Market is dominated by key players such as, Biogen Inc., Novartis AG, Editas Medicine, Inc., Regeneron Pharmaceuticals, Inc., and Amgen Inc.